FDA Approves Maintenance Lenalidomide for Multiple Myeloma

The FDA has expanded the approval of lenalidomide to include its use as maintenance therapy for patients with multiple myeloma following autologous stem cell transplant.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Hematologic Malignancies Multiple Myeloma News Source Type: news